CIK 0001850902 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alpha Teknova, Inc.
Sign in to watch- Ticker
- TKNO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943368109
- Phone
- 8316371100
- Business address
- 2451 BERT DRIVE, HOLLISTER, CA, 95023
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-14 | DEMSKI MARTHA J Director | Other disposition | −12,000 | 0 | ||
| 2026-07-14 | DEMSKI MARTHA J Director | Other acquisition | +12,000 | 12,000 | ||
| 2026-06-01 | Vos Alexander Director | Grant or award · Non-Qualified Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2026-06-01 | ROBERTSON BRETT Director | Grant or award · Non-Qualified Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2026-06-01 | DEMSKI MARTHA J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2026-03-06 | Gunstream Stephen President and CEO | Purchase | +26,000 | $2.15 | $56K | 269,497 |
| 2026-03-06 | Lowell Matthew Chief Financial Officer | Purchase | +40,000 | $2.19 | $88K | 168,376 |
| 2026-02-15 | Gunstream Stephen President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +429,000 | 429,000 | ||
| 2026-02-15 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +171,000 | 171,000 | ||
| 2026-02-15 | Terrill Damon General Counsel and CCO | Grant or award · Non-Qualified Stock Option (right to buy) | +148,000 | 148,000 | ||
| 2025-06-27 | DEMSKI MARTHA J Director | Sale 10b5-1 | −8,000 | $5.06 | $41K | 12,000 |
| 2025-06-17 | Vos Alexander Director | Grant or award · Non-Qualified Stock Option (right to buy) | +54,300 | 54,300 | ||
| 2025-06-17 | ROBERTSON BRETT Director | Grant or award · Non-Qualified Stock Option (right to buy) | +54,300 | 54,300 | ||
| 2025-06-17 | DEMSKI MARTHA J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +54,300 | 54,300 | ||
| 2025-06-17 | Vos Alexander Director | Grant or award | +54,300 | 102,472 | ||
| 2025-06-17 | ROBERTSON BRETT Director | Grant or award | +54,300 | 102,472 | ||
| 2025-06-17 | DEMSKI MARTHA J Director | Grant or award | +54,300 | 74,300 | ||
| 2025-02-27 | ROBERTSON BRETT Director | Other acquisition | +5,000 | 5,000 | ||
| 2025-02-14 | Terrill Damon General Counsel and CCO | Grant or award · Non-Qualified Stock Option (right to buy) | +137,808 | 137,808 | ||
| 2025-02-14 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +169,857 | 169,857 |
Page 1 of 6 · 106 trades